In The News
Latest News Update
- Amarantus BioSciences Receives Notice of Allowance for U.S. Patent Covering MANF Discovery
SUNNYVALE, CA--(Marketwire -10/20/11)- Amarantus BioSciences, Inc. (OTC.BB: AMBS.OB - News), a biotechnology company developing a first-in-class disease-modifying therapeutic protein that addresses an underlying form of cell death known as apoptosis, announced today that it has received a Notice of�
- PositiveID Corporation Expands Its Biological Detection Capabilities to Address Avian Flu
With the Company's MicroFluidic Systems Technology, It Can Quickly and Specifically Adapt Its Platform to Test for Any Bacteria or Virus and Provide Results in MinutesDELRAY BEACH, Fla., Sept. 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCBB:PSID.OB - News�
- PositiveID Corporation Announces Second Quarter 2011 Accomplishments and Mid-Year Update
Mid-year highlights include the submission of iglucose 510(k) to the FDA and U.S. Department of Homeland Security validation of the Company's recently launched multiplex biothreat assayAdditional highlights include the acquisition of MicroFluidic Systems, financing commitments for up to $13.8 million�
- Webcast Teleconference Announcement for NXOI Shareholder Update on Monday: August 8th, 2011, 11:00am
FORT LAUDERDALE, FL--(Marketwire -08/03/11)- Next One Interactive, Inc. (OTC.BB: NXOI), announced that Management will conduct a Shareholder Update via webcast teleconference to highlight, some of the upcoming phases, goals, progressions and achievements on several Next One divisions. There will be�
- Entest BioMedical Inc. Signs Letter of Intent to Acquire Assets of Oregon-Based Veterinary Clinic
Entest's Management Believes Transaction Could Result in $900,000 in Annual Revenue to the Company Based on Historical Financials SAN DIEGO, CA--(Marketwire - 07/25/11) - Entest BioMedical Inc. (OTCQB: ENTB) (OTC.BB:ENTB - News) announced that on July 19, 2011 a letter of intent (LOI) was executed�
- Entest BioMedical Inc. Signs Letter of Intent to Acquire Assets of Oregon-Based Veterinary Clinic
Entest's Management Believes Transaction Could Result in $900,000 in Annual Revenue to the Company Based on Historical Financials SAN DIEGO, CA--(Marketwire - 07/25/11) - Entest BioMedical Inc. (OTCQB: ENTB) (OTC.BB:ENTB - News) announced that on July 19, 2011 a letter of intent (LOI) was executed�
- Force Fuels Announces Engagement Letter with Carroll Energy for Preliminary Geological and Drilling
COSTA MESA, Calif., July 5, 2011 /PRNewswire/ -- Force Fuels Inc (OTC-BB:FOFU.ob - News) -- The Company announces the signing of an engagement Letter with Carroll Energy to prepare the preliminary Geological reports needed to drill 15 new wells on the properties Force Fuels acquired.This program�
